摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3S,5S)-5-[(2R,4R,5S)-5-[(2R,4S,5S)-5-amino-3,4-dihydroxy-6-methyloxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol

中文名称
——
中文别名
——
英文名称
(3S,5S)-5-[(2R,4R,5S)-5-[(2R,4S,5S)-5-amino-3,4-dihydroxy-6-methyloxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol
英文别名
——
(3S,5S)-5-[(2R,4R,5S)-5-[(2R,4S,5S)-5-amino-3,4-dihydroxy-6-methyloxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol化学式
CAS
——
化学式
C18H33NO14
mdl
——
分子量
487.5
InChiKey
DRGQLGDCWCCNHB-GKRBOPCTSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -6.6
  • 重原子数:
    33
  • 可旋转键数:
    6
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    254
  • 氢给体数:
    10
  • 氢受体数:
    15

文献信息

  • Anionic Conjugates of Glycosylated Bacterial Metabolite
    申请人:GLYCAN BIOSCIENCES LLC
    公开号:US20140323422A1
    公开(公告)日:2014-10-30
    The invention relates to anionic conjugates of glycosylated bacterial metabolites that may be used to mimic the structure and/or activity of the anionic bioactive molecules known as glycosaminoglycans (GAGs). The invention also relates to processes for the preparation of the conjugates. Such conjugates are useful in the prophylaxis and/or treatment of disease conditions and in particular chronic disease conditions such as inflammatory (including allergic) diseases, metastatic cancers and infection by pathogenic agents including bacteria, viruses or parasites.
  • ANIONIC CONJUGATES OF GLYCOSYLATED BACTERIAL METABOLITE
    申请人:GLYCAN BIOSCIENCES LLC
    公开号:US20160303243A1
    公开(公告)日:2016-10-20
    The invention relates to anionic conjugates of glycosylated bacterial metabolites that may be used to mimic the structure and/or activity of the anionic bioactive molecules known as glycosaminoglycans (GAGs). The invention also relates to processes for the preparation of the conjugates. Such conjugates are useful in the prophylaxis and/or treatment of disease conditions and in particular chronic disease conditions such as inflammatory (including allergic) diseases, metastatic cancers and infection by pathogenic agents including bacteria, viruses or parasites.
  • US8791245B2
    申请人:——
    公开号:US8791245B2
    公开(公告)日:2014-07-29
  • US9346845B2
    申请人:——
    公开号:US9346845B2
    公开(公告)日:2016-05-24
查看更多